STOCK TITAN

[Form 4] Kineta, Inc. Common Stock Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Director Richard Peters of Kineta reported multiple transactions on June 23-25, 2025:

  • Exercised 12,500 stock options at $0.611 per share on June 23
  • Disposed of 4,706 shares at $0.26 per share through share withholding (F code)
  • Received 6,000 shares as a new grant on June 25 at $0 cost

The transactions were part of a broader corporate event involving a merger agreement between Kineta and TuHURA Biosciences. Per the Optionholder Treatment Agreement dated June 16, 2025, and following stockholder approval on June 23, 2025, Peters' options under the 2022 Equity Incentive Plan became fully vested.

Following these transactions, Peters directly owns 101,891 shares of Kineta common stock. The option exercise eliminated his remaining derivative securities position.

Il direttore Richard Peters di Kineta ha segnalato diverse operazioni dal 23 al 25 giugno 2025:

  • Ha esercitato 12.500 opzioni su azioni a $0,611 per azione il 23 giugno
  • Ha ceduto 4.706 azioni a $0,26 per azione tramite ritenuta azionaria (codice F)
  • Ha ricevuto 6.000 azioni come nuova assegnazione il 25 giugno a costo zero

Queste operazioni facevano parte di un evento aziendale più ampio relativo a un accordo di fusione tra Kineta e TuHURA Biosciences. In base all'Accordo sul Trattamento degli Opzionisti datato 16 giugno 2025 e successivamente all'approvazione degli azionisti il 23 giugno 2025, le opzioni di Peters previste dal Piano di Incentivi Azionari 2022 sono diventate totalmente maturate.

A seguito di queste operazioni, Peters detiene direttamente 101.891 azioni ordinarie di Kineta. L'esercizio delle opzioni ha eliminato la sua posizione residua in titoli derivati.

El director Richard Peters de Kineta informó múltiples transacciones entre el 23 y el 25 de junio de 2025:

  • Ejerció 12,500 opciones sobre acciones a $0.611 por acción el 23 de junio
  • Dispuso de 4,706 acciones a $0.26 por acción mediante retención de acciones (código F)
  • Recibió 6,000 acciones como nueva concesión el 25 de junio sin costo

Estas transacciones formaron parte de un evento corporativo más amplio relacionado con un acuerdo de fusión entre Kineta y TuHURA Biosciences. Según el Acuerdo de Tratamiento de Titulares de Opciones fechado el 16 de junio de 2025 y tras la aprobación de los accionistas el 23 de junio de 2025, las opciones de Peters bajo el Plan de Incentivos de Capital 2022 quedaron completamente consolidadas.

Tras estas transacciones, Peters posee directamente 101,891 acciones ordinarias de Kineta. El ejercicio de las opciones eliminó su posición restante en valores derivados.

Kineta의 이사 Richard Peters는 2025년 6월 23일부터 25일까지 여러 거래를 보고했습니다:

  • 6월 23일에 주당 $0.611에 12,500주 스톡옵션을 행사함
  • 주식 원천징수(F 코드)를 통해 주당 $0.26에 4,706주를 처분함
  • 6월 25일에 비용 없이 6,000주를 신규 부여받음

이 거래들은 Kineta와 TuHURA Biosciences 간의 합병 계약과 관련된 광범위한 기업 이벤트의 일부였습니다. 2025년 6월 16일자 옵션 보유자 처리 계약과 6월 23일 주주 승인에 따라, Peters의 2022년 주식 인센티브 계획에 따른 옵션이 완전히 확정되었습니다.

이 거래 후, Peters는 Kineta 보통주 101,891주를 직접 보유하게 되었습니다. 옵션 행사를 통해 남아 있던 파생 증권 포지션이 해소되었습니다.

Le directeur Richard Peters de Kineta a déclaré plusieurs transactions du 23 au 25 juin 2025 :

  • Exercice de 12 500 options d'achat d'actions à 0,611 $ par action le 23 juin
  • Cession de 4 706 actions à 0,26 $ par action via une retenue d'actions (code F)
  • Réception de 6 000 actions en tant que nouvelle attribution le 25 juin sans coût

Ces transactions faisaient partie d’un événement d’entreprise plus large impliquant un accord de fusion entre Kineta et TuHURA Biosciences. Selon l’Accord de traitement des détenteurs d’options daté du 16 juin 2025 et après approbation des actionnaires le 23 juin 2025, les options de Peters dans le cadre du Plan d’Incitation au Capital 2022 sont devenues entièrement acquises.

À la suite de ces opérations, Peters détient directement 101 891 actions ordinaires de Kineta. L’exercice des options a permis d’éliminer sa position résiduelle en titres dérivés.

Direktor Richard Peters von Kineta meldete mehrere Transaktionen vom 23. bis 25. Juni 2025:

  • Am 23. Juni wurden 12.500 Aktienoptionen zu je $0,611 ausgeübt
  • 4.706 Aktien wurden zu $0,26 pro Aktie durch Aktieneinbehaltung (F-Code) veräußert
  • Am 25. Juni erhielt er 6.000 Aktien als neue Zuteilung ohne Kosten

Die Transaktionen waren Teil eines größeren Unternehmensereignisses im Zusammenhang mit einem Fusionsvertrag zwischen Kineta und TuHURA Biosciences. Gemäß der Optionsinhaber-Behandlungsvereinbarung vom 16. Juni 2025 und nach der Zustimmung der Aktionäre am 23. Juni 2025 wurden Peters' Optionen aus dem Equity Incentive Plan 2022 vollständig unverfallbar.

Nach diesen Transaktionen hält Peters direkt 101.891 Aktien der Kineta-Stammaktien. Durch die Ausübung der Optionen wurde seine verbleibende Position in derivativen Wertpapieren aufgelöst.

Positive
  • None.
Negative
  • None.

Il direttore Richard Peters di Kineta ha segnalato diverse operazioni dal 23 al 25 giugno 2025:

  • Ha esercitato 12.500 opzioni su azioni a $0,611 per azione il 23 giugno
  • Ha ceduto 4.706 azioni a $0,26 per azione tramite ritenuta azionaria (codice F)
  • Ha ricevuto 6.000 azioni come nuova assegnazione il 25 giugno a costo zero

Queste operazioni facevano parte di un evento aziendale più ampio relativo a un accordo di fusione tra Kineta e TuHURA Biosciences. In base all'Accordo sul Trattamento degli Opzionisti datato 16 giugno 2025 e successivamente all'approvazione degli azionisti il 23 giugno 2025, le opzioni di Peters previste dal Piano di Incentivi Azionari 2022 sono diventate totalmente maturate.

A seguito di queste operazioni, Peters detiene direttamente 101.891 azioni ordinarie di Kineta. L'esercizio delle opzioni ha eliminato la sua posizione residua in titoli derivati.

El director Richard Peters de Kineta informó múltiples transacciones entre el 23 y el 25 de junio de 2025:

  • Ejerció 12,500 opciones sobre acciones a $0.611 por acción el 23 de junio
  • Dispuso de 4,706 acciones a $0.26 por acción mediante retención de acciones (código F)
  • Recibió 6,000 acciones como nueva concesión el 25 de junio sin costo

Estas transacciones formaron parte de un evento corporativo más amplio relacionado con un acuerdo de fusión entre Kineta y TuHURA Biosciences. Según el Acuerdo de Tratamiento de Titulares de Opciones fechado el 16 de junio de 2025 y tras la aprobación de los accionistas el 23 de junio de 2025, las opciones de Peters bajo el Plan de Incentivos de Capital 2022 quedaron completamente consolidadas.

Tras estas transacciones, Peters posee directamente 101,891 acciones ordinarias de Kineta. El ejercicio de las opciones eliminó su posición restante en valores derivados.

Kineta의 이사 Richard Peters는 2025년 6월 23일부터 25일까지 여러 거래를 보고했습니다:

  • 6월 23일에 주당 $0.611에 12,500주 스톡옵션을 행사함
  • 주식 원천징수(F 코드)를 통해 주당 $0.26에 4,706주를 처분함
  • 6월 25일에 비용 없이 6,000주를 신규 부여받음

이 거래들은 Kineta와 TuHURA Biosciences 간의 합병 계약과 관련된 광범위한 기업 이벤트의 일부였습니다. 2025년 6월 16일자 옵션 보유자 처리 계약과 6월 23일 주주 승인에 따라, Peters의 2022년 주식 인센티브 계획에 따른 옵션이 완전히 확정되었습니다.

이 거래 후, Peters는 Kineta 보통주 101,891주를 직접 보유하게 되었습니다. 옵션 행사를 통해 남아 있던 파생 증권 포지션이 해소되었습니다.

Le directeur Richard Peters de Kineta a déclaré plusieurs transactions du 23 au 25 juin 2025 :

  • Exercice de 12 500 options d'achat d'actions à 0,611 $ par action le 23 juin
  • Cession de 4 706 actions à 0,26 $ par action via une retenue d'actions (code F)
  • Réception de 6 000 actions en tant que nouvelle attribution le 25 juin sans coût

Ces transactions faisaient partie d’un événement d’entreprise plus large impliquant un accord de fusion entre Kineta et TuHURA Biosciences. Selon l’Accord de traitement des détenteurs d’options daté du 16 juin 2025 et après approbation des actionnaires le 23 juin 2025, les options de Peters dans le cadre du Plan d’Incitation au Capital 2022 sont devenues entièrement acquises.

À la suite de ces opérations, Peters détient directement 101 891 actions ordinaires de Kineta. L’exercice des options a permis d’éliminer sa position résiduelle en titres dérivés.

Direktor Richard Peters von Kineta meldete mehrere Transaktionen vom 23. bis 25. Juni 2025:

  • Am 23. Juni wurden 12.500 Aktienoptionen zu je $0,611 ausgeübt
  • 4.706 Aktien wurden zu $0,26 pro Aktie durch Aktieneinbehaltung (F-Code) veräußert
  • Am 25. Juni erhielt er 6.000 Aktien als neue Zuteilung ohne Kosten

Die Transaktionen waren Teil eines größeren Unternehmensereignisses im Zusammenhang mit einem Fusionsvertrag zwischen Kineta und TuHURA Biosciences. Gemäß der Optionsinhaber-Behandlungsvereinbarung vom 16. Juni 2025 und nach der Zustimmung der Aktionäre am 23. Juni 2025 wurden Peters' Optionen aus dem Equity Incentive Plan 2022 vollständig unverfallbar.

Nach diesen Transaktionen hält Peters direkt 101.891 Aktien der Kineta-Stammaktien. Durch die Ausübung der Optionen wurde seine verbleibende Position in derivativen Wertpapieren aufgelöst.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Peters Richard

(Last) (First) (Middle)
C/O KINETA, INC.
7683 SE 27TH STREET, SUITE 481

(Street)
MERCER ISLAND WA 98040

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
KINETA, INC./DE [ KANT ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
06/23/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 06/23/2025 M 12,500 A $0.611 100,597 D
Common Stock 06/23/2025 F 4,706 D $0.26 95,891 D
Common Stock 06/25/2025 A 6,000 A $0 101,891 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy) $0.611 06/23/2025 M 12,500 (1) 09/03/2034 Common Stock 12,500 $0 0 D
Explanation of Responses:
1. Pursuant to the terms of (i) the Optionholder Treatment Agreement, dated June 16, 2025, by and between Kineta, Inc. (the "Company") and the Reporting Person, and (ii) the Agreement and Plan of Merger, dated as of December 11, 2024, by and among the Company, TuHURA Biosciences, Inc., a Nevada corporation ("TuHURA"), Hura Merger Sub I, Inc., a Delaware corporation and a wholly owned subsidiary of TuHURA, Hura Merger Sub II, a Delaware limited liability company and a wholly owned subsidiary of TuHURA, and Craig Philips, as representative of the stockholders of the Company, and as amended by that certain First Amendment to Agreement and Plan of Merger, dated May 5, 2025, as approved by the Company's stockholders at the Special Meeting of Stockholders held on June 23, 2025, the options granted to the Reporting Person under the 2022 Equity Incentive Plan became fully vested on June 23, 2025.
/s/ Nanette Agustines, as Attorney-in-Fact 06/25/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did Richard Peters make in KA stock on June 23, 2025?

On June 23, 2025, Richard Peters executed multiple transactions: He exercised 12,500 stock options at $0.611 per share (acquired), then disposed of 4,706 shares at $0.26 per share. Additionally, on June 25, 2025, he acquired 6,000 shares at $0.

How many shares of Kineta (KA) does Richard Peters own after these transactions?

Following all reported transactions, Richard Peters beneficially owns 101,891 shares of Kineta (KA) common stock directly.

What was the exercise price of the KA stock options that Richard Peters exercised?

Richard Peters exercised stock options with a strike price of $0.611 per share. These options were originally set to expire on September 3, 2034, but were exercised early on June 23, 2025.

Why did Richard Peters' KA stock options vest early in June 2025?

The stock options vested early on June 23, 2025, due to the Optionholder Treatment Agreement dated June 16, 2025, and the Agreement and Plan of Merger with TuHURA Biosciences, Inc., which was approved by stockholders at the Special Meeting on June 23, 2025.
Kineta, Inc.

NASDAQ:KA

KA Rankings

KA Latest News

KA Latest SEC Filings

KA Stock Data

7.05M
12.26M
34.89%
6%
0.23%
Biotechnology
Pharmaceutical Preparations
Link
United States
MERCER ISLAND